Astellas Pharma Inc. (TYO:4503)
2,391.50
+32.50 (1.38%)
Sep 25, 2026, 11:30 AM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 4.23 trillion as of September 24, 2026. Its market cap has increased by 41.47% in one year.
Market Cap
4.23T
Enterprise Value
4.58T
Revenue
2.27T
Ranking
n/a
PE Ratio
11.62
Stock Price
2,391.50
ChartMarket Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.23T, an increase of 379.10%. That is a compound annual growth rate of 4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.23T | 12.82% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.10T |
| Takeda Pharmaceutical Company | 9.40T |
| HOYA Corporation | 7.75T |
| Otsuka Holdings | 5.84T |
| Daiichi Sankyo Company | 5.38T |
| Terumo | 3.30T |
| Shionogi & | 2.48T |
| Olympus | 2.13T |